Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hayakawa, M.
Right arrow Articles by Osawa, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayakawa, M.
Right arrow Articles by Osawa, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (1994) 9: 655-661
© 1994 European Renal Association-European Dialysis and Transplant Association


research-article

Cytokine production and cytotoxicity of lymphocytes in patients on maintenance short- or long-term haemodialysis

M. Hayakawa, T. Hatano, I. Higa and A. Osawa

Department of Urology, School of Medicine, University of the Ryukyus Okinawa, Japan

Correspondence and offprint requests to: Correspondence and offprint requests to: Masamichi Hayakawa, c/o Department of Urology, Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, Japan

The lymphocyte-mediated cytotoxicity and cytokine production of patients under maintenance haemodialysis were studied. The patients were subdivided into two groups; 27 patients receiving haemodialysis treatment for up to 3 years (group 1) and 27 patients for longer than 10 years (group 2). Twenty-six healthy volunteers (group 3) were used as controls. The immunological parameters assayed were NK cell and lymphokine-activated killer (LAK) cell activities, and production of both interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha by either peripheral blood mononuclear cells (PBMC) cultured with IL-2 or LAK cells.

In group 1 both NK- and LAK-cell-mediated cyto-toxicities were significantly suppressed as compared to those in group 3. The titre of IFN produced by LAK cells was also less than that in group 3. On the contrary there were no significant differences in cytokine production by PBMC in all three groups. Percentage of the cases with suppressed cytokine production seemed higher in group 1 than group 3. In addition there was a close correlation between the value of IFN-gamma and of TNF-alpha produced by PBMC in the patients on haemodialysis. Both the type of dialysis membranes used and the primary diseases did not significantly influence the results in group 1 and group 2. From these results it could be speculated that there are more patients with impaired immune function in group 1 than in group 3. In contrast there was no significant difference in the immune function tested between group 2 and group 3.

Our results indicate the need for a study on time kinetics concerning the change in suppressed immune function of the patients and their clinical courses shortly after the beginning of haemodialysis.

Keywords: cytokine production; haemodialysis; LAK cell activity; NK cell activity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
H. Vacher-Coponat, C. Brunet, L. Lyonnet, E. Bonnet, A. Loundou, J. Sampol, V. Moal, B. Dussol, P. Brunet, Y. Berland, et al.
Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1406 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Vraetz, T. H. Ittel, M. G. van Mackelenbergh, P. C. Heinrich, H. G. Sieberth, and L. Graeve
Regulation of {beta}2-microglobulin expression in different human cell lines by proinflammatory cytokines
Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2137 - 2143.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.